SCFAs inhibit DNA methyltransferases (e.g., DNMT1), leading to demethylation and re-expression of tumor suppressor genes (e.g., SFRP2, WIF1), which in turn inhibit Wnt signaling and tumor growth (Feitelson et al., 2023). This evidence concerns the gene SFRP2 and neoplasm.